title: Orlistat associated subacute hepatic failure.
authors.forename: J L
authors.initials: JL
authors.lastname: Montero
authors.forename: J
authors.initials: J
authors.lastname: Muntané
authors.forename: E
authors.initials: E
authors.lastname: Fraga
authors.forename: M
authors.initials: M
authors.lastname: Delgado
authors.forename: G
authors.initials: G
authors.lastname: Costán
authors.forename: M
authors.initials: M
authors.lastname: Serrano
authors.forename: J
authors.initials: J
authors.lastname: Padillo
authors.forename: M
authors.initials: M
authors.lastname: de la Mata
authors.forename: G
authors.initials: G
authors.lastname: Miño
mesh_terms: D000328:Adult; D019440:Anti-Obesity Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D017093:Liver Failure / Q000139:chemically induced*; D000077403:Orlistat
chemical_list: D019440:Anti-Obesity Agents; D007783:Lactones; D000077403:Orlistat